DRUGSwww.epgonline.orgDISEASE KNOWLEDGE CENTRESwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgMEDICAL NEWSwww.epgonline.orgLINKSwww.epgonline.org
Members Login
How to use the
Email

Password



EPG News Feed Medical News
EPG Online Disease Knowledge Centres Feed Disease Knowledge
Recent UK Drug Updates Drug Updates
EPG Search
Frequent Searches:
Search
Languages

Medical News Headlines
Expert praises Parkinson's treatment
The treatment of Parkinson's disease with levodopa has been discussed...
Published Thursday 04 December 2008

Annual report finds cancer initiative a success
A new initiative that aims to improve the treatment of...
Published Thursday 04 December 2008

New game could help tackle obesity and diabetes in kids, expert claims
A new scheme from the British Heart Foundation (BHF) will...
Published Thursday 04 December 2008

Some "good cholesterol" not good enough, study suggests
A number of preconceptions about "good" HDL cholesterol have been...
Published Tuesday 02 December 2008

More Medical News
Browse Other Languages
(WHO) classifies chronic myeloid leukaemia (CML) as a myeloproliferative disease characterised by the presence of the Philadelphia chromosome (Ph) or the BCR-ABL fusion oncogene Clinical symptoms and signs of DVT are unreliable. DVT may present with pain, erythema, tenderness, and swelling of the affected limb. Alzheimer's disease (AD) is a progressive, neurodegenerative disease which will affect most of us at one point in time, and it’s prevalence increases with age. The prognosis of patients with diabetes is improved by interventions that reduce HbA1C
More NewsEPG Online News
Drug-resistant tuberculosis on the increase in the UK
02 May 2008

Doctors in the United Kingdom are being warned that the changing population structure is causing a rise in the number of cases of drug resistant tuberculosis.

A study published on bmj.com shows that cases of tuberculosis in England, Wales and Northern Ireland has been on the increase with more than 8,000 cases reported in 2006.

It adds that it is particularly concerning that the figures show an increasing transmission of drug resistant tuberculosis among difficult to treat, marginalised groups in urban areas such as London, and the problems this could create for tuberculosis control.

Research in to 28,620 confirmed cases of tuberculosis between 1998 and 2005 showed that the proportion of cases resistant to any first line drug had increased from 5.6 per cent to 7.9 per cent.

Within this there was an increasing proportion of isoniazid resistance (6.9 per cent) and small increases in rifampicin resistance (1.2 per cent) and multidrug resistance (0.9 per cent).

Analyses of the origin of patients showed an increase in the number of cases in people from Sub-Saharan Africa and the Indian subcontinent that researchers believe could be related.

Dr Michelle Kruijshaar and colleagues involved in the research said the analysis highlights the importance of early case detection by clinicians, rapid testing of susceptibility to drugs, additional support services to ensure that patients complete treatment and more help with tuberculosis control in countries with high incidence.

The report authors add that the levels of drug resistant tuberculosis seen in the UK are similar to those in other Western European countries - and suggest that most multidrug resistance cases occur due to problems with patient management rather than as a result of transmission within the UK.

Click here for EPG Online physician’s tools including disease awareness, diagnosis tools, treatment options and management guidance.ADNFCR-1419-ID-18578571-ADNFCR

Print Article    Bookmark Bookmark
Related News Stories (Clinical / Disease-specific News)

FEATURES

DRUG UPDATES Drug updates feed

EMAIL BULLETINS

MEDICAL NEWS EPG News Feed

DISEASE CENTRES Disease Centres feed

RESEARCH

GOOGLE SEARCH

GUIDELINES

DRUG DATA UK Drug Data Feed